Board of Directors

Dr. Paul M. Ness is currently the Director of Transfusion Medicine at Johns Hopkins Hospital in Baltimore, Maryland, and Professor of Pathology, Medicine, and Oncology at the Johns Hopkins University School of Medicine. He received his undergraduate degree at the Massachusetts Institute of Technology and his medical education at the State University of New York at Buffalo. He was an intern at SUNY Buffalo and a medical resident at Johns Hopkins Hospital. He did a hematology-oncology fellowship at the University of California San Francisco and a blood bank-transfusion medicine fellowship at the Irwin Memorial Blood Bank (now Blood Centers of the Pacific). He is board certified by the American Board of Internal Medicine in Medicine, Hematology, and Medical Oncology, and the American Board of Pathology in Blood Banking/Transfusion Medicine.

In addition to his position at Johns Hopkins which he has held since 1979, he was the chief executive officer and senior medical director of the Greater Chesapeake and Potomac Region of the American Red Cross Blood Services. He has held a number of positions with the AABB including President. He is currently the editor in chief of the journal Transfusion.  Dr. Ness has written approximately 150 scientific papers, 25 book chapters, and is the editor of two major texts in transfusion medicine. He has also served as a consultant to numerous for profit and non-profit organizations dealing with many aspects of transfusion medicine and alternatives to transfusion.

Dr. Ness has major research interests in transfusion alternatives such as hemodilution and blood substitutes. He is currently the Principal Investigator for the Johns Hopkins site of the Transfusion Medicine/ Hemostasis Clinical Trial Network sponsored by NHLBI. Dr. Ness also has been involved in research and teaching efforts in blood safety domestically and internationally. He is a consultant to the coordinating center for the REDS II program and the co-PI for the China program in the REDS II International Program. He also has research programs in other areas of transfusion complications such as animal models of alloimmunization and delayed serologic/hemolytic transfusion reactions.